FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378573936> ?p ?o ?g. }

• W4378573936 abstract "Previous studies have demonstrated epidemiological trends in individual metastatic cancer subtypes; however, research forecasting long-term incidence trends and projected survivorship of metastatic cancers is lacking. We assess the burden of metastatic cancer to 2040 by (1) characterizing past, current, and forecasted incidence trends, and (2) estimating odds of long-term (5-year) survivorship.This retrospective, serial cross-sectional, population-based study used registry data from the Surveillance, Epidemiology, and End Results (SEER 9) database. Average annual percentage change (AAPC) was calculated to describe cancer incidence trends from 1988 to 2018. Autoregressive integrating moving average (ARIMA) models were used to forecast the distribution of primary metastatic cancer and metastatic cancer to specific sites from 2019 to 2040 and JoinPoint models were fitted to estimate mean projected annual percentage change (APC).The average annual percent change (AAPC) in incidence of metastatic cancer decreased by 0.80 per 100,000 individuals (1988-2018) and we forecast an APC decrease by 0.70 per 100,000 individuals (2018-2040). Analyses predict a decrease in metastases to liver (APC = -3.40, 95% CI [-3.50, -3.30]), lung (APC (2019-2030) = -1.90, 95% CI [-2.90, -1.00]); (2030-2040) = -3.70, 95% CI [-4.60, -2.80]), bone (APC = -4.00, 95% CI [-4.30, -3.70]), and brain (APC = -2.30, 95% CI [-2.60, -2.00]). By 2040, patients with metastatic cancer are predicted to have 46.7% greater odds of long-term survivorship, driven by increasing plurality of patients with more indolent forms of metastatic disease.By 2040, the distribution of metastatic cancer patients is predicted to shift in predominance from invariably fatal to indolent cancers subtypes. Continued research on metastatic cancers is important to guide health policy and clinical intervention efforts, and direct allocations of healthcare resources.Cancer that has spread beyond the area where it originated and into different organs is called metastatic cancer. This study analyzed trends in metastatic cancer incidence, the proportion of those with metastatic cancer surviving 5 years after diagnosis and the locations in the body each cancer had spread to. The incidence of metastatic cancer decreased between 1988 and 2018 and is expected to continue to decrease until 2040. Some of the most common locations cancer spreads to is the lung, liver, brain, and bone. Metastatic cancer incidence to these areas is predicted to decrease. Also, the likelihood of surviving for more than 5 years after diagnosis with metastatic cancer is predicted to increase by 2040. This research should facilitate optimal planning of future healthcare resources and policy." @default.
• W4378573936 created "2023-05-28" @default.
• W4378573936 creator A5001530469 @default.
• W4378573936 creator A5004366838 @default.
• W4378573936 creator A5007015662 @default.
• W4378573936 creator A5014270544 @default.
• W4378573936 creator A5027188615 @default.
• W4378573936 creator A5044571272 @default.
• W4378573936 creator A5076238068 @default.
• W4378573936 creator A5078402900 @default.
• W4378573936 creator A5082428650 @default.
• W4378573936 creator A5085787232 @default.
• W4378573936 creator A5086084361 @default.
• W4378573936 date "2023-05-27" @default.
• W4378573936 modified "2023-10-10" @default.
• W4378573936 title "Future trends in incidence and long-term survival of metastatic cancer in the United States" @default.
• W4378573936 cites W2006303017 @default.
• W4378573936 cites W2024492396 @default.
• W4378573936 cites W2024504834 @default.
• W4378573936 cites W2077618811 @default.
• W4378573936 cites W2118141787 @default.
• W4378573936 cites W2137144083 @default.
• W4378573936 cites W2140811091 @default.
• W4378573936 cites W2160720185 @default.
• W4378573936 cites W2168133848 @default.
• W4378573936 cites W2230150749 @default.
• W4378573936 cites W2262981828 @default.
• W4378573936 cites W2287868019 @default.
• W4378573936 cites W2314635417 @default.
• W4378573936 cites W2468004496 @default.
• W4378573936 cites W2468071338 @default.
• W4378573936 cites W2529386894 @default.
• W4378573936 cites W2604488831 @default.
• W4378573936 cites W2768573365 @default.
• W4378573936 cites W2783414919 @default.
• W4378573936 cites W2803786798 @default.
• W4378573936 cites W2890381929 @default.
• W4378573936 cites W2901219667 @default.
• W4378573936 cites W2911831872 @default.
• W4378573936 cites W2925207003 @default.
• W4378573936 cites W2939770857 @default.
• W4378573936 cites W2967213355 @default.
• W4378573936 cites W2980161450 @default.
• W4378573936 cites W3011086465 @default.
• W4378573936 cites W3019363045 @default.
• W4378573936 cites W3107300149 @default.
• W4378573936 cites W3108932994 @default.
• W4378573936 cites W3146983201 @default.
• W4378573936 cites W3184091959 @default.
• W4378573936 cites W3200770938 @default.
• W4378573936 cites W3200804649 @default.
• W4378573936 cites W4292616398 @default.
• W4378573936 doi "https://doi.org/10.1038/s43856-023-00304-x" @default.
• W4378573936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37244961" @default.
• W4378573936 hasPublicationYear "2023" @default.
• W4378573936 type Work @default.
• W4378573936 citedByCount "0" @default.
• W4378573936 crossrefType "journal-article" @default.
• W4378573936 hasAuthorship W4378573936A5001530469 @default.
• W4378573936 hasAuthorship W4378573936A5004366838 @default.
• W4378573936 hasAuthorship W4378573936A5007015662 @default.
• W4378573936 hasAuthorship W4378573936A5014270544 @default.
• W4378573936 hasAuthorship W4378573936A5027188615 @default.
• W4378573936 hasAuthorship W4378573936A5044571272 @default.
• W4378573936 hasAuthorship W4378573936A5076238068 @default.
• W4378573936 hasAuthorship W4378573936A5078402900 @default.
• W4378573936 hasAuthorship W4378573936A5082428650 @default.
• W4378573936 hasAuthorship W4378573936A5085787232 @default.
• W4378573936 hasAuthorship W4378573936A5086084361 @default.
• W4378573936 hasBestOaLocation W43785739361 @default.
• W4378573936 hasConcept C107130276 @default.
• W4378573936 hasConcept C120665830 @default.
• W4378573936 hasConcept C121332964 @default.
• W4378573936 hasConcept C121608353 @default.
• W4378573936 hasConcept C126322002 @default.
• W4378573936 hasConcept C143095724 @default.
• W4378573936 hasConcept C143998085 @default.
• W4378573936 hasConcept C144024400 @default.
• W4378573936 hasConcept C149923435 @default.
• W4378573936 hasConcept C151956035 @default.
• W4378573936 hasConcept C156957248 @default.
• W4378573936 hasConcept C172400760 @default.
• W4378573936 hasConcept C2778527826 @default.
• W4378573936 hasConcept C2908647359 @default.
• W4378573936 hasConcept C61511704 @default.
• W4378573936 hasConcept C71924100 @default.
• W4378573936 hasConcept C99454951 @default.
• W4378573936 hasConceptScore W4378573936C107130276 @default.
• W4378573936 hasConceptScore W4378573936C120665830 @default.
• W4378573936 hasConceptScore W4378573936C121332964 @default.
• W4378573936 hasConceptScore W4378573936C121608353 @default.
• W4378573936 hasConceptScore W4378573936C126322002 @default.
• W4378573936 hasConceptScore W4378573936C143095724 @default.
• W4378573936 hasConceptScore W4378573936C143998085 @default.
• W4378573936 hasConceptScore W4378573936C144024400 @default.
• W4378573936 hasConceptScore W4378573936C149923435 @default.
• W4378573936 hasConceptScore W4378573936C151956035 @default.
• W4378573936 hasConceptScore W4378573936C156957248 @default.
• W4378573936 hasConceptScore W4378573936C172400760 @default.
• W4378573936 hasConceptScore W4378573936C2778527826 @default.

• next